Get the Stockscreener App
46.26
0.13%
0.06
Springworks Therapeutics Inc stock is traded at $46.26, with a volume of 3.74M.
It is up +0.13% in the last 24 hours and up +24.62% over the past month.
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.
See More
Previous Close:
$46.20
Open:
$46.19
24h Volume:
3.74M
Relative Volume:
0.81
Market Cap:
$3.47B
Revenue:
-
Net Income/Loss:
$-275.16M
P/E Ratio:
-11.89
EPS:
-3.89
Net Cash Flow:
$-221.15M
1W Performance:
+0.06%
1M Performance:
+24.62%
6M Performance:
+36.10%
1Y Performance:
+7.71%
1-Day Range:
$46.16
$46.26
1-Week Range:
$46.10
$46.27
52-Week Range:
$28.21
$62.00
Springworks Therapeutics Inc Stock (SWTX) Company Profile
Name
Springworks Therapeutics Inc
Sector
Industry
Phone
203-883-9490
Address
100 WASHINGTON BOULEVARD, STAMFORD, CT
Compare SWTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
46.26 | 3.47B | 0 | -275.16M | -221.15M | -3.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-24 | Initiated | Evercore ISI | Outperform |
| Feb-05-24 | Initiated | Guggenheim | Buy |
| Dec-01-22 | Initiated | BofA Securities | Buy |
| Jan-19-21 | Reiterated | H.C. Wainwright | Buy |
| Oct-29-20 | Reiterated | H.C. Wainwright | Buy |
| May-05-20 | Initiated | Barclays | Overweight |
| Mar-19-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Mar-04-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-21-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-04-19 | Initiated | H.C. Wainwright | Buy |
| Oct-08-19 | Initiated | Cowen | Outperform |
| Oct-08-19 | Initiated | Goldman | Buy |
| Oct-08-19 | Initiated | JP Morgan | Overweight |
| Oct-08-19 | Initiated | Wedbush | Outperform |
View All
Springworks Therapeutics Inc Stock (SWTX) Latest News
The Manufacturers Life Insurance Company Acquires 122,128 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Decoding SpringWorks Therapeutics Inc (SWTX): A Strategic SWOT I - GuruFocus
Duquesne Family Office LLC Buys 154,628 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq
SpringWorks Therapeutics: Q1 Earnings Snapshot - Greenwich Time
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Deep Track Capital LP - MarketBeat
ArrowMark Colorado Holdings LLC Boosts Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
The Pharma Letter M&A roundupApril 2025 - The Pharma Letter
Boxer Capital Management LLC Buys New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics Retail Chatter Spikes As Germany’s Merck Confirms Late-Stage Talks For $3.5B Buyout - MSN
Ally Bridge Group NY LLC Has $1.98 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Cut to Hold at Evercore ISI - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Earns "Neutral" Rating from HC Wainwright - MarketBeat
Soros Fund Management LLC Purchases 41,149 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
TD Cowen Reaffirms Hold Rating for SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
Merck KGaA (MKGAF) to Acquire SpringWorks Therapeutics for $3.9 Billion - GuruFocus
(SWTX) Trading Report - news.stocktradersdaily.com
Merck KGaA’s $3.9 Billion Springworks Deal to Boost US Presence - MSN
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap UpHere's Why - MarketBeat
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $63.17 - MarketBeat
Wedbush Reiterates "Neutral" Rating for SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Receives "Equal Weight" Rating from Barclays - MarketBeat
Price T Rowe Associates Inc. MD Sells 241,632 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Nebula Research & Development LLC - MarketBeat
SpringWorks Therapeutics’ (SWTX) “Neutral” Rating Reiterated at HC Wainwright - Defense World
Top Mid Cap Stocks Worth WatchingApril 28th - MarketBeat
Voya Investment Management LLC Acquires 67,559 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Taxation With Representation: Goodwin, Haynes Boone - Law360
Lord Abbett & CO. LLC Trims Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, SWTX on Behalf of Shareholders - marketscreener.com
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives $63.17 Consensus Price Target from Brokerages - Defense World
SpringWorks Therapeutics (NASDAQ:SWTX) Cut to “Hold” at Evercore ISI - Defense World
SpringWorks Therapeutics (SWTX) Downgraded Amid Acquisition Deal - GuruFocus
13,556 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Syon Capital LLC - MarketBeat
SPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc.SWTX - Business Wire
HC Wainwright Downgrades Springworks Therapeutics to Neutral From Buy, Adjusts Price Target to $47 From $74 - marketscreener.com
SpringWorks Therapeutics (SWTX) Downgraded by H.C. Wainwright Du - GuruFocus
SpringWorks Therapeutics (SWTX) Downgraded by H.C. Wainwright Due to Merck Deal | SWTX Stock News - GuruFocus
Merck KGaA Nears Deal to Buy SpringWorks Therapeutics - MSN
Springworks Therapeutics Inc Stock (SWTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):